Jing Liang

ORCID: 0000-0003-0480-0390
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Endometrial and Cervical Cancer Treatments
  • Molecular Biology Techniques and Applications
  • Erythrocyte Function and Pathophysiology
  • Acute Lymphoblastic Leukemia research
  • Neurogenetic and Muscular Disorders Research
  • Genetic factors in colorectal cancer
  • Radiomics and Machine Learning in Medical Imaging
  • Chronic Myeloid Leukemia Treatments
  • Intracranial Aneurysms: Treatment and Complications
  • Moyamoya disease diagnosis and treatment
  • Erythropoietin and Anemia Treatment
  • Chronic Lymphocytic Leukemia Research
  • Cervical Cancer and HPV Research
  • Autophagy in Disease and Therapy
  • Pancreatic function and diabetes
  • MRI in cancer diagnosis
  • Cannabis and Cannabinoid Research
  • biodegradable polymer synthesis and properties
  • Neuroscience and Neuropharmacology Research
  • Amyotrophic Lateral Sclerosis Research
  • Intracerebral and Subarachnoid Hemorrhage Research

Tianjin Medical University Cancer Institute and Hospital
2024-2025

University of Chinese Academy of Sciences
2023

Institute of Psychology, Chinese Academy of Sciences
2023

Second Affiliated Hospital of Xinjiang Medical University
2022

Xinjiang Medical University
2022

Institute of Hematology & Blood Diseases Hospital
2021

Chinese Academy of Medical Sciences & Peking Union Medical College
2021

ZheJiang Institute For Food and Drug Control
2020

Weizmann Institute of Science
2019

Erythropoietin (EPO) drives erythropoiesis and is secreted mainly by the kidney upon hypoxic or anemic stress. The paucity of EPO production in renal EPO-producing cells (REPs) causes anemia, one most common complications chronic nephropathies. Although mitochondrial dysfunction commonly observed several hematopoietic disorders, mechanism which quality control impacts anemia remains elusive. In this study, we showed that FUNDC1, a mitophagy receptor, plays critical role EPO-driven induced...

10.7554/elife.64480 article EN cc-by eLife 2021-05-04

Intracranial aneurysmal subarachnoid hemorrhage (aSAH) is a dangerous and highly fatal condition if ruptured. Significant advances have been made in the treatment of unruptured intracranial aneurysms (UIAs), but risk assessment methods for early diagnosis aneurysm (IA) rupture remain limited.The datasets IA GSE13353, GSE15629, GSE54083 were downloaded through Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) ruptured identified by R software using such as gene set...

10.21037/atm-22-4068 article EN Annals of Translational Medicine 2022-09-09
Coming Soon ...